Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

Market Cap	18.69B
Revenue (ttm)	432.14M
Net Income (ttm)	-186.95M
Shares Out	159.27M
EPS (ttm)	-1.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,934,600
Average Volume	15,309,622
Open	124.90
Previous Close	117.35
Day's Range	113.54 - 124.90
52-Week Range	24.44 - 188.93
Beta	1.01
RSI	52.52
Earnings Date	Oct 24, 2025

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, anti-infection, liver diseases, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 760
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300436

Financial Performance

In 2024, SHE:300436's revenue was 441.46 million, an increase of 4.43% compared to the previous year's 422.71 million. Losses were -156.30 million, -55.16% less than in 2023.